• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SWK Holdings Corporation filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    4/10/25 4:40:24 PM ET
    $SWKH
    Diversified Financial Services
    Finance
    Get the next $SWKH alert in real time by email
    swkh-20250410
    0001089907FALSE00010899072025-04-102025-04-100001089907us-gaap:CommonStockMember2025-04-102025-04-100001089907us-gaap:SeniorNotesMember2025-04-102025-04-10


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    FORM 8-K
     
    CURRENT REPORT
     
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (Date of Earliest Event Reported): April 10, 2025
     
    SWK HOLDINGS CORPORATION
    (Exact Name of the Registrant as Specified in Its Charter)
     
    Delaware
    (State or Other Jurisdiction of Incorporation)
     
    F11.001-39184
    77-0435679
    (Commission File Number)(IRS Employer Identification No.)
      
    5956 Sherry Lane, Suite 650, Dallas, TX
    75225
    (Address of Principal Executive Offices)(Zip Code)
     
    (972) 687-7250
    (Registrant’s Telephone Number, Including Area Code)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each classTrading Symbol(s)Name of each exchange on
    which registered
    Common Stock, par value
    $0.001 per share
    SWKHThe Nasdaq Stock Market LLC
    9.00% Senior Notes due 2027SWKHLThe Nasdaq Stock Market LLC
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).           Emerging growth company   
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
     




    Item 2.01 Completion of Acquisition or Disposition of Assets.
    As previously disclosed in the Current Report on Form 8-K filed by SWK Holdings Corporation (the “Company”), with the Securities and Exchange Commission (the “SEC”) on March 20, 2025, the Company entered into a purchase and sale agreement (the “Purchase and Sale Agreement”) with SCOF SPV I, LP, a Delaware limited partnership and an entity affiliated with Soleus Capital Management L.P. (the “Purchaser”) on March 19, 2025 for the sale and assignment to Purchaser (the “Royalty Sale”) of the Company’s rights to receive royalties and other amounts payable or that may become payable under certain contracts to which SWK Funding LLC, a wholly owned subsidiary of the Company (“SWK Funding”), is a party, comprising the majority of the Company’s royalty portfolio for an aggregate purchase price of approximately $34.0 million. On April 10, 2025, the Company completed the transactions contemplated by the Purchase and Sale Agreement and Purchaser paid the Company approximately $34.0 million in cash and assumed certain related liabilities.
    A copy of the unaudited pro forma consolidated financial statements of the Company, giving effect to the Royalty Sale, are attached as Exhibit 99.2 to this Current Report on Form 8-K and are incorporated herein by reference.
    Item 7.01 Regulation FD Disclosure.
    On April 10, 2025, the Company issued a press release announcing the closing of the Royalty Sale and the declaration of a cash dividend (as further discussed in Item 8.01 of this Current Report on Form 8-K). A copy of the press release is attached hereto as Exhibit 99.1.
    The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
    Item 8.01 Other Events.
    On April 10, 2025, the Company announced that its Board of Directors declared a cash dividend of $4 per share of common stock. The dividend is payable on May 8, 2025 to stockholders of record as of the close of business on April 24, 2025.
    Item 9.01 Financial Statements and Exhibits.
    (b) Pro forma financial information.
    The unaudited pro forma consolidated financial statements of the Company as of and for the year ended December 31, 2024 and the notes related thereto, giving effect to the Royalty Sale, are filed as Exhibit 99.2 to this Current Report on Form 8-K and incorporated herein by reference.
    (d) Exhibits

    Exhibit No. Description
    99.1
    Press Release of SWK Holdings Corp, dated April 10, 2025
    99.2
    Unadudited Pro Forma Condensed Consolidated Financial Information for SWK Holdings Corporation
    104
    Cover Page Interactive Date File (embedded within the Inline XBRL document)






    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     
    SWK HOLDINGS CORPORATION
      
    By: /s/ Joe D. Staggs
     Joe D. Staggs
     President and Chief Executive Officer
     
    Date: April 10, 2025
      
     
     

    Get the next $SWKH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SWKH

    DatePrice TargetRatingAnalyst
    12/28/2022$26.00Buy
    Lake Street
    4/18/2022$26.00Buy
    Lake Street
    More analyst ratings

    $SWKH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Runway Growth Finance Corp. to Acquire SWK Holdings Corporation

    Acquisition of high-quality portfolio centered on healthcare and life sciences investments Accelerates strategy to diversify and optimize portfolio while adding significant scale Enhances financial profile and is expected to be accretive to net investment income ("NII") MENLO PARK, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (NASDAQ:RWAY) ("Runway Growth" or the "Company"), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it has entered into a definitive merger agreement to acquire SWK Holdings Corporation (NASDAQ:SWKH) ("SWK"), a life science focused specialty fi

    10/9/25 5:45:24 PM ET
    $RWAY
    $SWKH
    Finance: Consumer Services
    Finance
    Diversified Financial Services

    Callodine Group Appoints Winston Black as Head of Life Sciences Finance Strategy

    Callodine Group ("Callodine") is pleased to announce the appointment of Winston Black as the Head of Callodine's newly formed Life Sciences Finance Strategy. In this role, Mr. Black will lead the firm's efforts in sourcing, underwriting, and managing structured investments across the life sciences sector, with a focus on commercial-stage companies. Mr. Black brings more than 25 years of investment and operational experience, with deep domain expertise in life sciences finance. He has been active in the space since 2005 and has invested over $1 billion in similar strategies across the capital structure. His proven ability to navigate complex transactions and his established network of clin

    7/31/25 8:30:00 AM ET
    $SWKH
    Diversified Financial Services
    Finance

    ImpediMed Secures $15m Growth Capital Funding

    New round will help fuel commercialization efforts in support of ImpediMed's platform technology for the detection and monitoring of lymphedema. CARLSBAD, Calif., Feb. 7, 2025 /PRNewswire/ -- ImpediMed, a leader in medical technologies to clinically monitor and manage fluid and body composition, today announced an agreement for a five-year $15 million growth capital facility with SWK Holdings (NASDAQ:SWKH), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies. Funds raised will provide ImpediMed with funding flexibility and will be used to support growth and commercialization activities. Armentum Partners acted as the Company's exclusiv

    2/7/25 11:00:00 AM ET
    $SWKH
    Diversified Financial Services
    Finance

    $SWKH
    SEC Filings

    View All

    SWK Holdings Corporation filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - SWK Holdings Corp (0001089907) (Filer)

    12/5/25 4:10:22 PM ET
    $SWKH
    Diversified Financial Services
    Finance

    SEC Form 425 filed by SWK Holdings Corporation

    425 - SWK Holdings Corp (0001089907) (Subject)

    12/4/25 5:18:54 PM ET
    $SWKH
    Diversified Financial Services
    Finance

    SWK Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - SWK Holdings Corp (0001089907) (Filer)

    12/4/25 5:18:40 PM ET
    $SWKH
    Diversified Financial Services
    Finance

    $SWKH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hatcher Robert K. was granted 3,858 shares, increasing direct ownership by 30% to 16,662 units (SEC Form 4)

    4 - SWK Holdings Corp (0001089907) (Issuer)

    6/18/25 8:16:45 PM ET
    $SWKH
    Diversified Financial Services
    Finance

    Director Albright Jerry was granted 3,858 shares, increasing direct ownership by 55% to 10,832 units (SEC Form 4)

    4 - SWK Holdings Corp (0001089907) (Issuer)

    6/18/25 8:16:24 PM ET
    $SWKH
    Diversified Financial Services
    Finance

    Director Dotter Laurie L. was granted 3,858 shares, increasing direct ownership by 30% to 16,791 units (SEC Form 4)

    4 - SWK Holdings Corp (0001089907) (Issuer)

    6/18/25 8:15:58 PM ET
    $SWKH
    Diversified Financial Services
    Finance

    $SWKH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on SWK Holdings with a new price target

    Lake Street resumed coverage of SWK Holdings with a rating of Buy and set a new price target of $26.00

    12/28/22 9:18:49 AM ET
    $SWKH
    Diversified Financial Services
    Finance

    Lake Street initiated coverage on SWK Holdings with a new price target

    Lake Street initiated coverage of SWK Holdings with a rating of Buy and set a new price target of $26.00

    4/18/22 8:44:23 AM ET
    $SWKH
    Diversified Financial Services
    Finance

    $SWKH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SWK Holdings Corporation

    SC 13G/A - SWK Holdings Corp (0001089907) (Subject)

    11/14/24 11:49:47 AM ET
    $SWKH
    Diversified Financial Services
    Finance

    Amendment: SEC Form SC 13D/A filed by SWK Holdings Corporation

    SC 13D/A - SWK Holdings Corp (0001089907) (Subject)

    10/25/24 4:05:56 PM ET
    $SWKH
    Diversified Financial Services
    Finance

    SEC Form SC 13G/A filed by SWK Holdings Corporation (Amendment)

    SC 13G/A - SWK Holdings Corp (0001089907) (Subject)

    2/14/24 2:14:12 PM ET
    $SWKH
    Diversified Financial Services
    Finance

    $SWKH
    Financials

    Live finance-specific insights

    View All

    Runway Growth Finance Corp. to Acquire SWK Holdings Corporation

    Acquisition of high-quality portfolio centered on healthcare and life sciences investments Accelerates strategy to diversify and optimize portfolio while adding significant scale Enhances financial profile and is expected to be accretive to net investment income ("NII") MENLO PARK, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (NASDAQ:RWAY) ("Runway Growth" or the "Company"), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it has entered into a definitive merger agreement to acquire SWK Holdings Corporation (NASDAQ:SWKH) ("SWK"), a life science focused specialty fi

    10/9/25 5:45:24 PM ET
    $RWAY
    $SWKH
    Finance: Consumer Services
    Finance
    Diversified Financial Services

    SWK Holdings Corporation Announces Financial Results for Third Quarter 2024

    Conference Call Scheduled for Friday, November 15, 2024, at 09:00 a.m. CSTCorporate HighlightsThird quarter 2024 GAAP net income was $3.5 million, compared with GAAP net income of $4.5 million for the third quarter 2023.Third quarter 2024 finance receivables segment adjusted non-GAAP net income was $5.0 million, compared with adjusted non-GAAP net income of $5.8 million for the third quarter 2023.As of September 30, 2024, net finance receivables were $255.9 million, a 14.4% increase from September 30, 2023.The third quarter 2024 effective yield was 14.6%, a 60 basis points increase from third quarter 2023.As of September 30, 2024, GAAP book value per share was $22.94, a 3.7% increase from $2

    11/14/24 4:15:00 PM ET
    $SWKH
    Diversified Financial Services
    Finance

    SWK Holdings Provides Portfolio Update

    Company Announces Q3 Earnings and Conference Call Dates DALLAS, TX / ACCESSWIRE / October 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update and announced the anticipated date of the third quarter earnings and conference call schedule.The Company intends to issue their third quarter financials after market close on November 14, 2024, and will host a conference call at 9:00 a.m. Central Time on November 15, 2024, to discuss the company's financial results for the quarter. Call details will be available in the quarterly results

    10/17/24 4:15:00 PM ET
    $BTCY
    $DERM
    $ELUT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    $SWKH
    Leadership Updates

    Live Leadership Updates

    View All

    Callodine Group Appoints Winston Black as Head of Life Sciences Finance Strategy

    Callodine Group ("Callodine") is pleased to announce the appointment of Winston Black as the Head of Callodine's newly formed Life Sciences Finance Strategy. In this role, Mr. Black will lead the firm's efforts in sourcing, underwriting, and managing structured investments across the life sciences sector, with a focus on commercial-stage companies. Mr. Black brings more than 25 years of investment and operational experience, with deep domain expertise in life sciences finance. He has been active in the space since 2005 and has invested over $1 billion in similar strategies across the capital structure. His proven ability to navigate complex transactions and his established network of clin

    7/31/25 8:30:00 AM ET
    $SWKH
    Diversified Financial Services
    Finance

    Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

    January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announced today the appointment of Dr Gary A. Shangold as Chief Medical Officer with immediate effect. Commenting, Stephen Stamp, CEO and CFO of Biodexa said: "I am delighted to welcome Gary to the team. As Biodexa moves towards the later clinical stages including an upcoming global Phase 3 registrational study in FAP, it is essential we access specialists

    1/22/25 8:30:00 AM ET
    $BDRX
    $JNJ
    $SWKH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Diversified Financial Services
    Finance

    SWK Holdings Appoints Chief Financial Officer

    Company Also Promotes Controller DALLAS, TX / ACCESSWIRE / July 8, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, is pleased to announce the appointment of Adam C. Rice, CPA, as Chief Financial Officer (CFO) of the company and the promotion of Courtney Baker, CPA, to Controller.With over 18 years of senior-level finance and accounting leadership experience, Rice has led financial operations management, corporate financial planning and analysis, strategic planning and financial statement reporting. He was previously CFO of Park Cities Asset Management, an SEC

    7/8/24 5:00:00 PM ET
    $SWKH
    Diversified Financial Services
    Finance